Elan Inkomsten in het verleden
Verleden criteriumcontroles 5/6
Elan has been growing earnings at an average annual rate of 19.4%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 15.8% per year. Elan's return on equity is 22.7%, and it has net margins of 5.8%.
Belangrijke informatie
19.4%
Groei van de winst
19.5%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 7.9% |
| Inkomstengroei | 15.8% |
| Rendement op eigen vermogen | 22.7% |
| Nettomarge | 5.8% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe Elan geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 44,489 | 2,591 | 6,617 | 0 |
| 31 Mar 24 | 43,055 | 2,550 | 6,450 | 0 |
| 31 Dec 23 | 41,426 | 2,519 | 6,086 | 0 |
| 30 Sep 23 | 39,925 | 2,207 | 5,986 | 0 |
| 30 Jun 23 | 38,441 | 2,158 | 5,804 | 0 |
| 31 Mar 23 | 37,329 | 2,151 | 5,676 | 0 |
| 31 Dec 22 | 36,265 | 2,083 | 5,636 | 0 |
| 30 Sep 22 | 35,121 | 2,186 | 5,544 | 0 |
| 30 Jun 22 | 34,021 | 2,126 | 5,414 | 0 |
| 31 Mar 22 | 32,904 | 2,024 | 5,259 | 0 |
| 31 Dec 21 | 31,635 | 1,905 | 5,078 | 0 |
| 30 Sep 21 | 30,481 | 1,886 | 4,895 | 0 |
| 30 Jun 21 | 29,112 | 1,738 | 4,771 | 0 |
| 31 Mar 21 | 27,592 | 1,613 | 4,603 | 0 |
| 31 Dec 20 | 26,056 | 1,446 | 4,495 | 0 |
| 30 Sep 20 | 24,611 | 1,276 | 4,294 | 0 |
| 30 Jun 20 | 23,340 | 1,132 | 4,191 | 0 |
| 31 Mar 20 | 22,410 | 1,038 | 4,110 | 0 |
| 31 Dec 19 | 21,518 | 989 | 3,980 | 0 |
| 30 Sep 19 | 20,642 | 960 | 3,870 | 0 |
| 30 Jun 19 | 19,930 | 952 | 3,758 | 0 |
| 31 Mar 19 | 19,174 | 929 | 3,625 | 0 |
| 31 Dec 18 | 18,585 | 865 | 3,548 | 0 |
| 30 Sep 18 | 17,939 | 861 | 3,387 | 0 |
| 30 Jun 18 | 17,296 | 772 | 3,343 | 0 |
| 31 Mar 18 | 16,673 | 694 | 3,307 | 0 |
| 31 Dec 17 | 15,466 | 657 | 3,084 | 0 |
Kwaliteitswinsten: 6099 has a high level of non-cash earnings.
Groeiende winstmarge: 6099's current net profit margins (5.8%) are higher than last year (5.6%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 6099's earnings have grown by 19.4% per year over the past 5 years.
Versnelling van de groei: 6099's earnings growth over the past year (20.1%) exceeds its 5-year average (19.4% per year).
Winst versus industrie: 6099 earnings growth over the past year (20.1%) exceeded the Healthcare industry 9.6%.
Rendement op eigen vermogen
Hoge ROE: 6099's Return on Equity (22.7%) is considered high.